Work

WCN25-2412 COMBINED INDUCTION THERAPY WITH RABBIT ANTI-THYMOCYTE GLOBULIN (rATG) AND RITUXIMAB IN COMPARISON WITH rATG ALONE ON RENAL ALLOGRAFT OUTCOMES IN NON-SENSITIZED LIVE RECIPIENTS

Year: 2025

Type: article

Abstract: Antibody-mediated rejections are the most common cause of graft loss. Induction therapy with ATG is T cell centric leaving B cells uninhibited leading to acute rejections and antibody-mediated IF/TA in the long term. Combined T cell and B cell inhibition might prevent Acute rejections, ABMR and improve graft survival.

Source: Kidney International Reports

DOI: 10.1016/j.ekir.2024.11.915

Authors: Praveen G, Rohan Augustine, Sudarshan Ballal, Vishwanath siddini

Institution: Manipal Hospital

Language: English

Topic: Renal Transplantation Outcomes and Treatments

Subfield: Transplantation

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,800